Stock-based Compensation (Details Narrative) - USD ($) |
3 Months Ended | 6 Months Ended | |||
---|---|---|---|---|---|
Jun. 20, 2019 |
Jun. 30, 2019 |
Jun. 30, 2018 |
Jun. 30, 2019 |
Jun. 30, 2018 |
|
Number of option purchase during period for vested | 9,000 | ||||
Number of options outstanding | 1,293,630 | 1,293,630 | |||
Stock-based compensation expense | $ 66,476 | $ 125,035 | |||
Stock option expenses | |||||
Employees [Member] | |||||
Stock option contractual term | 5 years | ||||
Stock option exercise price | $ 2.40 | ||||
Employees [Member] | Tranche One [Member] | In-license a new or additional drug [Member] | |||||
Number of stock option granted | 456,000 | ||||
Employees [Member] | Tranche Two [Member] | |||||
Number of stock option granted | 90,646 | ||||
Employees [Member] | Tranche Two [Member] | Phase 2a trial for PCS-499 Complete [Member] | |||||
Number of stock option granted | 90,646 | ||||
Employees [Member] | Tranche Two [Member] | Up-List From The OCTQB [Member] | |||||
Number of stock option granted | 271,938 |
X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. No definition available.
|
X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of options vested. No definition available.
|
X | ||||||||||
- Definition Amount of noncash expense for option under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|